Reading the Tea Leaves in FDA's AI-Enabled Device Guidelines

from Info Risk Today Podcast · host InfoRiskToday.com

While recent draft guidance from the Food and Drug Administration on artificial intelligence-enabled medical devices is non-binding, the document signals that the agency is intensifying its regulatory scrutiny of these technologies, said Dr. Scott Schell of IT consulting firm Cognizant.

Episode metadata supplied by the publisher feed · Published Mar 26, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Reading the Tea Leaves in FDA's AI-Enabled Device Guidelines

0:00 0:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

When was this Info Risk Today Podcast episode published?

This episode was published on March 26, 2025.

Can I download this Info Risk Today Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!